DUPIXENT (DUPILUMAB)

200 mg/1.14 mL subcutaneous syringe

• Inject 1.14 milliliters (200 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

300 mg/2 mL subcutaneous syringe

• Inject 2 milliliters (300 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

Atopic dermatitis

• Inject 2 milliliters (300 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

• Inject 1.71 milliliters (300 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

• Inject 3.42 milliliters (600 mg) once by subcutaneous route using 2 separate injection sites in the abdomen, thigh, or upper arm

• Inject 4 milliliters (600 mg) once by subcutaneous route using 2 separate injection sites in the abdomen, thigh, or upper arm

Chronic rhinosinusitis with nasal polyposis

• Inject 2 milliliters (300 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

• Inject 1.71 milliliters (300 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

Refractory extrinsic asthma

• Inject 1.14 milliliters (200 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

• Inject 2 milliliters (300 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

• Inject 1.71 milliliters (300 mg) by subcutaneous route every 2 weeks in the abdomen, thigh, or upper arm rotating injection sites

• Inject 2.28 milliliters (400 mg) once by subcutaneous route using 2 separate injection sites in the abdomen, thigh, or upper arm

• Inject 3.42 milliliters (600 mg) once by subcutaneous route using 2 separate injection sites in the abdomen, thigh, or upper arm

• Inject 4 milliliters (600 mg) once by subcutaneous route using 2 separate injection sites in the abdomen, thigh, or upper arm